Fig. 4. PLS-DA score plot of plasma samples after three weeks treatment
of PP242 at a dose of 60
mg.kg-1.day-1. (A) Metabolomics
(ES⁺; R² = 0.43, Q² = 0.1), (B) metabolomics (ES⁻; R² = 0.43, Q² =
0.21), (C) Lipidomics (ES⁺; R² = 0.61, Q² = 0.20), and Lipidomics (ES⁻;
R² = 0.51, Q² = 0.17).